Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Statistical considerations in biosimilar assessment using biosimilarity index

In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation

View More »

Google Scholar citation report
Citations : 4363

Journal of Bioequivalence & Bioavailability received 4363 citations as per Google Scholar report

Flyer image
Journal of Bioequivalence & Bioavailability peer review process verified at publons
Flyer image
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Flyer image
Open Access Journals
View More

Mylene Perreault

Mylene Perreault

Pfizer, USA

Biography
Mylene Perreault is an in vivo physiologist/pharmacologist with extensive drug discovery experience for type 2 diabetes and obesity programs. She had been Team leader and biology lead on several pre-clinical projects and proven experience as co-team leader on multiple clinical assets. She has also managed a group of BS/MS/PhD/Post-doctoral fellow and recognized as a very good communicator with excellent ability to work in a team environment. She had done her PhD in Physiology-Endocrinology from Université Laval in 2002
Research Interest
Drug Discovery In Vivo Drug Development Pharmacology Assay Development Pharmaceutical Industry Biotechnology Type 2 Diabetes Project Management in vivo physiology